According to the latest publication from Meticulous Research®, the pharmaceutical processing equipment market is projected to reach $14.09 billion by 2031, at a CAGR of 4.5% during the forecast period 2024–2031. The growth of this market is driven by the advantages offered by utilizing advanced pharmaceutical processing equipment, the growing demand for innovative drug formulations, and the rising awareness regarding medication safety. However, stringent regulatory frameworks and storage & handling issues may restrain market growth.

Furthermore, the rising demand from emerging economies is expected to create market growth opportunities. Additionally, the increasing adoption of automation and integration of advanced technologies are prominent trends in the pharmaceutical processing equipment market.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://www.meticulousresearch.com/download-sample-report/cp_id=4083?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-08-2024

Key Players

Some of the key players operating in the pharmaceutical processing equipment market are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius AG (Germany), GEA Group (Germany), SPX Flow, Inc. (U.S.), IDEX Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Merck KGaA (Germany), and Danaher Corporation (U.S.).

The pharmaceutical processing equipment market is segmented based on type (mixing & blending equipment, granulation equipment, tablet compression equipment, coating equipment, and others), form (solid, liquid, and semi-solid), application (drug development, drug manufacturing, and others), and geography (Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa). The study also evaluates industry competitors and analyzes the market at the regional and country levels.

Based on type, the mixing & blending equipment segment is expected to account for the largest share of 31.1% of the pharmaceutical processing equipment market in 2024. This segment’s large market share can be attributed to the rising demand for consistent and uniform mixtures in drug formulations and the growing focus on improving product quality and efficiency in pharmaceutical manufacturing.

Based on form, the solid segment is expected to account for the larger share of 92.7% of the pharmaceutical processing equipment market in 2024. This segment’s large market share is mainly attributed to the advantages offered by solid dosage forms over liquid and semi-solid forms, such as better stability, ease of handling & transport, and longer shelf life. Moreover, the solid segment is projected to register a higher growth rate of 4.7% during the forecast period of 2024–2031.

Browse full report: https://www.meticulousresearch.com/product/feed-premix-market-4083?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-08-2024

Based on application, the drug manufacturing segment is expected to account for the largest share of 46.0% of the pharmaceutical processing equipment market in 2024. This segment’s large market share is mainly attributed to the growing demand for efficient and high-quality drug production processes and the increasing focus on meeting stringent regulatory standards. However, the drug development segment is projected to register the highest growth rate of 5.4% during the forecast period of 2024–2031. This growth is driven by the increasing emphasis on innovative drug formulations and the rising global demand for new and effective medications.

Based on geography, in 2024, Asia-Pacific is expected to account for the largest share of 36.6% of the pharmaceutical processing equipment market. Asia-Pacific’s significant market share can be attributed to the growth in the pharmaceutical industry, rapid economic growth, increasing demand for advanced drug formulations in emerging and developing countries, including India, China, Indonesia, and Thailand, and rising investments from major players in the region.

Moreover, the market in Asia-Pacific is projected to register the highest growth rate of 5.5% during the forecast period. The growth of this regional market is driven by shifting consumption patterns, the industrialization of the pharmaceutical sector, instances of counterfeit medications, and regulations promoting the use of advanced processing technologies.

Buy now: https://www.meticulousresearch.com/Checkout/99501490?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-08-2024


Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123